As countries work to slow the spread of the virus that causes COVID-19, a new study shows why the methods they are currently using to screen international travelers may not be catching everyone who’s infected.
In a new study, the self-expanding, intracranial Wingspan brain stent seems effective over the long term in reducing stroke patients' risk of a subsequent stroke and death.
The disorder, called cleidocranial dysplasia (CCD), affects only about one in a million people, according to the U.S. National Institutes of Health. Caused by a mutated gene, CCD leads to abnormal bone development -- most apparent in the collarbones and teeth.
The device, which is controlled with a smartphone, looks like a swim cap with multiple magnetic microstimulators attached. Study volunteers wore it for 40 minutes per session, and completed 20 sessions over four weeks.
Compared to those without the AIDS-causing virus, people with HIV had a 34% higher rate of COPD and were diagnosed with the lung disease about 12 years earlier -- average age 50 versus 62, the investigators found.
